$EMMA
Emmaus Life Sciences, Inc.

2022 Q4 Form 10-Q Financial Statement

#000156459022037658 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $5.930M $4.939M $5.766M
YoY Change 96.36% -14.34% 2.95%
Cost Of Revenue $645.0K $540.0K $445.0K
YoY Change -67.77% 21.35% -8.06%
Gross Profit $5.285M $4.399M $5.321M
YoY Change 418.65% -17.33% 3.99%
Gross Profit Margin 89.12% 89.07% 92.28%
Selling, General & Admin $6.174M $4.627M $4.882M
YoY Change 25.85% -5.22% 8.97%
% of Gross Profit 116.82% 105.18% 91.75%
Research & Development $529.0K $432.0K $470.0K
YoY Change -50.93% -8.09% -25.28%
% of Gross Profit 10.01% 9.82% 8.83%
Depreciation & Amortization $13.00K $9.000K $11.00K
YoY Change -13.33% -18.18% -8.33%
% of Gross Profit 0.25% 0.2% 0.21%
Operating Expenses $6.703M $5.059M $5.352M
YoY Change 12.02% -5.47% 4.76%
Operating Profit -$1.418M -$660.0K -$31.00K
YoY Change -71.44% 2029.03% -487.5%
Interest Expense $1.564M $1.520M -$3.080M
YoY Change -153.47% -149.35% -291.78%
% of Operating Profit
Other Income/Expense, Net $150.0K $175.0K $192.0K
YoY Change -20.21% -8.85% -73.26%
Pretax Income $216.0K -$426.0K -$2.919M
YoY Change -103.13% -85.41% -149.66%
Income Tax $16.00K -$35.00K $232.0K
% Of Pretax Income 7.41%
Net Earnings $200.0K -$391.0K -$3.151M
YoY Change -102.91% -87.59% -156.42%
Net Earnings / Revenue 3.37% -7.92% -54.65%
Basic Earnings Per Share -$0.01 -$0.06
Diluted Earnings Per Share $0.00 -$0.01 -$63.90K
COMMON SHARES
Basic Shares Outstanding 49.56M 49.56M 49.31M
Diluted Shares Outstanding 49.56M 49.31M

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.021M $1.179M $2.321M
YoY Change -11.32% -49.2% -53.1%
Cash & Equivalents $2.021M $1.179M $2.321M
Short-Term Investments
Other Short-Term Assets $449.0K $511.0K $250.0K
YoY Change 13.96% 104.4% -56.29%
Inventory $2.379M $2.739M $6.252M
Prepaid Expenses $467.0K $328.0K $242.0K
Receivables $375.0K $1.491M $2.663M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $6.289M $6.382M $12.47M
YoY Change -30.82% -48.84% -69.5%
LONG-TERM ASSETS
Property, Plant & Equipment $75.00K $79.00K $97.00K
YoY Change -48.98% -18.56% -25.38%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $18.83M $16.59M $43.55M
YoY Change 6.88% -61.9% 200.68%
Other Assets $263.0K $259.0K $293.0K
YoY Change -10.85% -11.6% 0.69%
Total Long-Term Assets $41.94M $35.82M $47.58M
YoY Change -11.98% -24.72% 149.78%
TOTAL ASSETS
Total Short-Term Assets $6.289M $6.382M $12.47M
Total Long-Term Assets $41.94M $35.82M $47.58M
Total Assets $48.23M $42.20M $60.06M
YoY Change -15.0% -29.73% 0.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.785M $3.407M $1.822M
YoY Change 39.21% 86.99% -16.15%
Accrued Expenses $7.239M $5.729M $4.654M
YoY Change 24.81% 23.1% -5.64%
Deferred Revenue
YoY Change
Short-Term Debt $5.615M $7.452M $7.733M
YoY Change -35.51% -3.63% 378.53%
Long-Term Debt Due $21.47M $19.98M $3.269M
YoY Change 70.97% 511.23% -69.34%
Total Short-Term Liabilities $54.32M $41.52M $25.03M
YoY Change 46.42% 65.92% 5.24%
LONG-TERM LIABILITIES
Long-Term Debt $3.726M $3.381M $14.41M
YoY Change -19.87% -76.53% 311.07%
Other Long-Term Liabilities $21.71M $32.12M $32.28M
YoY Change -34.54% -0.47% -8.92%
Total Long-Term Liabilities $21.71M $32.12M $32.28M
YoY Change -34.54% -0.47% -24.11%
TOTAL LIABILITIES
Total Short-Term Liabilities $54.32M $41.52M $25.03M
Total Long-Term Liabilities $21.71M $32.12M $32.28M
Total Liabilities $82.32M $79.79M $75.16M
YoY Change 5.28% 6.16% 13.35%
SHAREHOLDERS EQUITY
Retained Earnings -$252.3M -$252.5M
YoY Change 4.59%
Common Stock $220.9M $220.9M
YoY Change 0.36%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$34.09M -$37.59M -$15.10M
YoY Change
Total Liabilities & Shareholders Equity $48.23M $42.20M $60.06M
YoY Change -15.0% -29.73% 0.19%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income $200.0K -$391.0K -$3.151M
YoY Change -102.91% -87.59% -156.42%
Depreciation, Depletion And Amortization $13.00K $9.000K $11.00K
YoY Change -13.33% -18.18% -8.33%
Cash From Operating Activities $1.677M -$954.0K $1.640M
YoY Change 93.87% -158.17% -162.05%
INVESTING ACTIVITIES
Capital Expenditures $8.000K $0.00 -$10.00K
YoY Change -112.9% -100.0%
Acquisitions
YoY Change
Other Investing Activities -$1.054M -$900.0K -$1.276M
YoY Change -0.85% -29.47% -104.02%
Cash From Investing Activities -$1.062M -$900.0K -$1.286M
YoY Change -5.6% -30.02% -104.05%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 170.0K 2.114M 300.0K
YoY Change -15.0% 604.67% -37.76%
NET CHANGE
Cash From Operating Activities 1.677M -954.0K 1.640M
Cash From Investing Activities -1.062M -900.0K -1.286M
Cash From Financing Activities 170.0K 2.114M 300.0K
Net Change In Cash 785.0K 260.0K 654.0K
YoY Change -1408.33% -60.24% -97.79%
FREE CASH FLOW
Cash From Operating Activities $1.677M -$954.0K $1.640M
Capital Expenditures $8.000K $0.00 -$10.00K
Free Cash Flow $1.669M -$954.0K $1.650M
YoY Change 80.04% -157.82% -162.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0000822370
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q3 us-gaap Equity Method Investments
EquityMethodInvestments
16594000
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
17616000
CY2022Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
14346000
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
32122000
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
540000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
470000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2963000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
5059000
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
dei Entity Registrant Name
EntityRegistrantName
EMMAUS LIFE SCIENCES, INC.
dei City Area Code
CityAreaCode
310
dei Local Phone Number
LocalPhoneNumber
214-0065
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
10158000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
41523000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
37100000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3261000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
33173000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35527
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
147000
CY2022Q3 emma Investment In Convertible Bond
InvestmentInConvertibleBond
15943000
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
49558501
CY2022Q3 emma Conversion Feature Derivative Note Payable
ConversionFeatureDerivativeNotePayable
4272000
CY2022Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
2780000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1380000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
6382000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
9091000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
79000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2944000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3485000
CY2021Q4 emma Investment In Convertible Bond
InvestmentInConvertibleBond
26100000
dei Entity Address Address Line1
EntityAddressAddressLine1
21250 Hawthorne Boulevard
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 800
dei Entity Address City Or Town
EntityAddressCityOrTown
Torrance
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90503
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1179000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2279000
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1491000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1040000
CY2022Q3 us-gaap Inventory Net
InventoryNet
2739000
CY2021Q4 us-gaap Inventory Net
InventoryNet
4392000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
973000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
259000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
295000
CY2022Q3 us-gaap Assets
Assets
42201000
CY2021Q4 us-gaap Assets
Assets
56734000
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
11134000
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
9189000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
653000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
740000
CY2021Q4 emma Conversion Feature Derivative Note Payable
ConversionFeatureDerivativeNotePayable
7507000
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2270000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4404000
CY2022Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
400000
CY2021Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
400000
CY2022Q3 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
33000
CY2021Q4 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
1503000
CY2022Q3 emma Notes Payable Current Excluding Convertible Notes Payable Current
NotesPayableCurrentExcludingConvertibleNotesPayableCurrent
5635000
CY2021Q4 emma Notes Payable Current Excluding Convertible Notes Payable Current
NotesPayableCurrentExcludingConvertibleNotesPayableCurrent
2399000
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
800000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49558501
CY2022Q3 us-gaap Gross Profit
GrossProfit
4399000
CY2021Q3 us-gaap Gross Profit
GrossProfit
5321000
us-gaap Gross Profit
GrossProfit
10517000
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49558501
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-252537000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-37589000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
42201000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4939000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5766000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12460000
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
445000
us-gaap Cost Of Revenue
CostOfRevenue
1943000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1196000
CY2021Q3 emma Gain Loss On Warrant Derivative Liabilities
GainLossOnWarrantDerivativeLiabilities
-131000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1490000
us-gaap Operating Income Loss
OperatingIncomeLoss
-5168000
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-421000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-421000
emma Gain Loss On Conversion Feature Derivative Note Payable
GainLossOnConversionFeatureDerivativeNotePayable
3235000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-660000
CY2022Q3 emma Gain Loss On Warrant Derivative Liabilities
GainLossOnWarrantDerivativeLiabilities
51000
emma Gain Loss On Warrant Derivative Liabilities
GainLossOnWarrantDerivativeLiabilities
1341000
CY2022Q3 emma Gain Loss On Conversion Feature Derivative Note Payable
GainLossOnConversionFeatureDerivativeNotePayable
3850000
CY2021Q3 emma Gain Loss On Conversion Feature Derivative Note Payable
GainLossOnConversionFeatureDerivativeNotePayable
-1357000
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-431000
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-663000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1999000
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1470000
CY2021Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-246000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-5131000
CY2022Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
175000
CY2021Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
192000
us-gaap Interest And Other Income
InterestAndOtherIncome
530000
CY2022Q3 us-gaap Interest Expense
InterestExpense
1520000
us-gaap Interest Expense
InterestExpense
3544000
CY2022Q3 emma Nonoperating Income Expense Including Income Loss From Equity Method Investments
NonoperatingIncomeExpenseIncludingIncomeLossFromEquityMethodInvestments
234000
CY2021Q3 emma Nonoperating Income Expense Including Income Loss From Equity Method Investments
NonoperatingIncomeExpenseIncludingIncomeLossFromEquityMethodInvestments
-2888000
emma Nonoperating Income Expense Including Income Loss From Equity Method Investments
NonoperatingIncomeExpenseIncludingIncomeLossFromEquityMethodInvestments
-5613000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-426000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2919000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10781000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-35000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
232000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
44000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-391000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-3151000
us-gaap Net Income Loss
NetIncomeLoss
-10825000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49311864
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49311864
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
49000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-255000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2764000
CY2022Q3 us-gaap Liabilities
Liabilities
79790000
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
50000
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
220803000
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5905000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-241266000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-21450000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
56734000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17590000
us-gaap Cost Of Revenue
CostOfRevenue
1311000
us-gaap Gross Profit
GrossProfit
16279000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3032000
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1664000
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1518000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5076000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4254000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10156000
us-gaap Operating Expenses
OperatingExpenses
17442000
us-gaap Operating Income Loss
OperatingIncomeLoss
-1163000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1172000
emma Gain Loss On Warrant Derivative Liabilities
GainLossOnWarrantDerivativeLiabilities
-322000
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2754000
us-gaap Interest Expense
InterestExpense
2390000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9026000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
58000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
481000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
86000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2566000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2668000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5819000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
2489000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-9375000
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
115000
CY2022Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5598000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
6228000
CY2022Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
4630000
CY2021Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1439000
CY2022Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
278000
CY2022Q3 us-gaap Inventory Net
InventoryNet
2739000
CY2021Q4 us-gaap Inventory Net
InventoryNet
4392000
CY2022Q3 us-gaap Prepaid Insurance
PrepaidInsurance
134000
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
660000
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
44000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
232000
CY2022Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
us-gaap Operating Lease Expense
OperatingLeaseExpense
868000
us-gaap Operating Lease Expense
OperatingLeaseExpense
889000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
3400000
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
emma Warrants Granted Term
WarrantsGrantedTerm
P5Y
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49558501
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49311864
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49397690
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49233371
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0419387
CY2021Q4 emma Long Term Notes Payable Excluding Convertible Long Term Notes Payable
LongTermNotesPayableExcludingConvertibleLongTermNotesPayable
1500000
CY2022Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
3381000
CY2021Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
3150000
CY2021Q4 us-gaap Liabilities
Liabilities
78184000
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
220022000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
432000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3364000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9413000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
5352000
us-gaap Operating Expenses
OperatingExpenses
15685000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-31000
emma Gain Loss On Conversion Feature Derivative Note Payable
GainLossOnConversionFeatureDerivativeNotePayable
-1132000
emma Gain Loss On Investment In Convertible Bond
GainLossOnInvestmentInConvertibleBond
-133000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1421000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
243000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-5650000
us-gaap Interest And Other Income
InterestAndOtherIncome
573000
CY2021Q3 us-gaap Interest Expense
InterestExpense
683000
emma Nonoperating Income Expense Including Income Loss From Equity Method Investments
NonoperatingIncomeExpenseIncludingIncomeLossFromEquityMethodInvestments
-7863000
us-gaap Net Income Loss
NetIncomeLoss
-9084000
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-3047000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-7112000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2150000
emma Other Comprehensive Income Loss Reclassification Adjustment For Loss Included In Net Income Loss
OtherComprehensiveIncomeLossReclassificationAdjustmentForLossIncludedInNetIncomeLoss
7000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1455000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1907000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2957000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16475000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10991000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49558501
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49311864
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49397690
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49233371
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-21450000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
350000
CY2022Q1 emma Other Comprehensive Income Loss Reclassification Adjustment For Loss Included In Net Income Loss
OtherComprehensiveIncomeLossReclassificationAdjustmentForLossIncludedInNetIncomeLoss
7000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
331000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1542000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-22299000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
213000
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
110000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5000
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-4415000
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
643000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-8892000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-34635000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3000
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-3047000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
481000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-391000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-37589000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-5158000
CY2021Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
500000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
181000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
58000
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
165000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-8422000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-12676000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
274000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
546000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
93000
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2754000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
86000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-3151000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-15101000
us-gaap Profit Loss
ProfitLoss
-10825000
us-gaap Profit Loss
ProfitLoss
-9084000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
40000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44000
emma Inventory Reserve
InventoryReserve
-1240000
emma Inventory Reserve
InventoryReserve
-423000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1303000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1410000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-5072000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-1415000
emma Equity Securities Fv Ni Realized Gain Loss Excluding Impairment Loss
EquitySecuritiesFvNiRealizedGainLossExcludingImpairmentLoss
-133000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1490000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1999000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-421000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1172000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
1000
emma Gain Loss On Sale Of Loss On Leased Assets
GainLossOnSaleOfLossOnLeasedAssets
-22000
us-gaap Share Based Compensation
ShareBasedCompensation
13000
us-gaap Share Based Compensation
ShareBasedCompensation
548000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
55000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
500000
emma Gain Loss On Warrant Derivative Liabilities
GainLossOnWarrantDerivativeLiabilities
1341000
emma Gain Loss On Warrant Derivative Liabilities
GainLossOnWarrantDerivativeLiabilities
-322000
emma Gain Loss On Conversion Feature Derivative Note Payable
GainLossOnConversionFeatureDerivativeNotePayable
3235000
emma Gain Loss On Conversion Feature Derivative Note Payable
GainLossOnConversionFeatureDerivativeNotePayable
-1132000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
485000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2469000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-390000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-404000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-148000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-202000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-446000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-417000
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
28000
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
15000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1479000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-173000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-3199000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
242000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
55000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-637000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6750000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2119000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
2919000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11000
emma Loan To Equity Method Investee
LoanToEquityMethodInvestee
-4226000
emma Loan To Equity Method Investee
LoanToEquityMethodInvestee
-5241000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1325000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5252000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
4283000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
5469000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1000000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
14490000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2689000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1079000
CY2021Q4 emma Accrued Non Employee Board Member Compensation
AccruedNonEmployeeBoardMemberCompensation
136000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
7200000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7063000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7211000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-88000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-6000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1100000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-166000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2279000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2487000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1179000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2321000
us-gaap Interest Paid Net
InterestPaidNet
817000
us-gaap Interest Paid Net
InterestPaidNet
840000
us-gaap Income Taxes Paid
IncomeTaxesPaid
16000
us-gaap Income Taxes Paid
IncomeTaxesPaid
43000
emma Debt Discount Due To Embedded Derivative
DebtDiscountDueToEmbeddedDerivative
68000
emma Debt Discount Due To Embedded Derivative
DebtDiscountDueToEmbeddedDerivative
5555000
emma Debt Discount Due To Deferred Financing Cost
DebtDiscountDueToDeferredFinancingCost
213000
emma Debt Discount Due To Warrants
DebtDiscountDueToWarrants
70000
us-gaap Net Income Loss
NetIncomeLoss
-10800000
CY2022Q3 emma Working Capital Deficit
WorkingCapitalDeficit
35100000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
52635590
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
23276594
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4939000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5766000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12460000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17590000
CY2021Q4 emma Revenue Allowance And Accrual Activities
RevenueAllowanceAndAccrualActivities
5153000
emma Revenue Allowance And Accrual Activities Provision Related To Sales In Current Year
RevenueAllowanceAndAccrualActivitiesProvisionRelatedToSalesInCurrentYear
3897000
emma Revenue Allowance And Accrual Activities Adjustments Related To Prior Period Sales
RevenueAllowanceAndAccrualActivitiesAdjustmentsRelatedToPriorPeriodSales
-531000
emma Revenue Allowance And Accrual Activities Credit And Payments Made
RevenueAllowanceAndAccrualActivitiesCreditAndPaymentsMade
5012000
CY2022Q3 emma Revenue Allowance And Accrual Activities
RevenueAllowanceAndAccrualActivities
4569000
CY2020Q4 emma Revenue Allowance And Accrual Activities
RevenueAllowanceAndAccrualActivities
2726000
emma Revenue Allowance And Accrual Activities Provision Related To Sales In Current Year
RevenueAllowanceAndAccrualActivitiesProvisionRelatedToSalesInCurrentYear
5189000
emma Revenue Allowance And Accrual Activities Adjustments Related To Prior Period Sales
RevenueAllowanceAndAccrualActivitiesAdjustmentsRelatedToPriorPeriodSales
90000
emma Revenue Allowance And Accrual Activities Credit And Payments Made
RevenueAllowanceAndAccrualActivitiesCreditAndPaymentsMade
3438000
CY2021Q3 emma Revenue Allowance And Accrual Activities
RevenueAllowanceAndAccrualActivities
4387000
CY2022Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1493000
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3390000
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
328000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
326000
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
511000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
394000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
973000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1380000
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
498000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
541000
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
420000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
394000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
79000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
147000
CY2022Q3 us-gaap Depreciation
Depreciation
9000
CY2021Q3 us-gaap Depreciation
Depreciation
11000
us-gaap Depreciation
Depreciation
30000
us-gaap Depreciation
Depreciation
34000
CY2020Q3 us-gaap Debt Instrument Call Date Earliest
DebtInstrumentCallDateEarliest
2020-09-28
CY2021 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-126000
CY2020 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-126000
CY2021 us-gaap Other Income
OtherIncome
41000
CY2020 us-gaap Other Income
OtherIncome
41000
CY2021 us-gaap Debt Instrument Convertible Number Of Equity Instruments
DebtInstrumentConvertibleNumberOfEquityInstruments
10173099
CY2022Q3 emma Accrued Government Rebates And Other Rebates Current
AccruedGovernmentRebatesAndOtherRebatesCurrent
4157000
CY2021Q4 emma Accrued Government Rebates And Other Rebates Current
AccruedGovernmentRebatesAndOtherRebatesCurrent
4371000
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
26100000
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
27866000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
-2919000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
-126000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
-7112000
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
-1766000
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
15943000
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
26100000
CY2022Q3 emma Cro Expenses
CROExpenses
444000
CY2021Q4 emma Cro Expenses
CROExpenses
534000
CY2022Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
579000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
477000
CY2022Q3 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
1138000
CY2021Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
932000
CY2022Q3 emma Accrued Manufacturing Expenses Current
AccruedManufacturingExpensesCurrent
532000
CY2021Q4 emma Accrued Manufacturing Expenses Current
AccruedManufacturingExpensesCurrent
378000
CY2022Q3 emma Accrued Non Employee Board Member Compensation
AccruedNonEmployeeBoardMemberCompensation
401000
CY2022Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1196000
CY2021Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1097000
CY2022Q3 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
313000
CY2021Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
262000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3407000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2719000
CY2022Q3 emma Interest Payable Related Parties Current
InterestPayableRelatedPartiesCurrent
325000
CY2021Q4 emma Interest Payable Related Parties Current
InterestPayableRelatedPartiesCurrent
91000
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
1673000
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
579000
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
376000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
332000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5729000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5800000
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
11134000
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
9189000
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2270000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4404000
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
32122000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
33173000
CY2022Q3 emma Debt Instrument Principal Outstanding Amount
DebtInstrumentPrincipalOutstandingAmount
29421000
CY2022Q3 emma Debt Instrument Principal Outstanding Amount
DebtInstrumentPrincipalOutstandingAmount
29421000
CY2022Q3 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
3273000
CY2022Q3 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
3273000
CY2022Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
26143000
CY2022Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
26143000
us-gaap Debt Instrument Convertible Number Of Equity Instruments
DebtInstrumentConvertibleNumberOfEquityInstruments
41432198
us-gaap Debt Instrument Convertible Number Of Equity Instruments
DebtInstrumentConvertibleNumberOfEquityInstruments
41432198
CY2021Q4 emma Debt Instrument Principal Outstanding Amount
DebtInstrumentPrincipalOutstandingAmount
22339000
CY2021Q4 emma Debt Instrument Principal Outstanding Amount
DebtInstrumentPrincipalOutstandingAmount
22339000
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
4332000
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
4332000
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
18007000
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
18007000
CY2021 us-gaap Debt Instrument Convertible Number Of Equity Instruments
DebtInstrumentConvertibleNumberOfEquityInstruments
10173099
CY2022Q3 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.07
CY2021Q4 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.06
CY2022Q3 emma Debt Weighted Average Effective Interest Rate
DebtWeightedAverageEffectiveInterestRate
0.19
CY2021Q4 emma Debt Weighted Average Effective Interest Rate
DebtWeightedAverageEffectiveInterestRate
0.15
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
25900000
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
1200000
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
2321000
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
29421000
CY2022Q3 emma Debt Instrument Principle Payments
DebtInstrumentPrinciplePayments
1600000
CY2022Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
32000
CY2022Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
84000
CY2022Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
500000
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.50
CY2022Q3 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
33000
CY2022Q3 emma Gain Loss On Warrant Derivative Liabilities
GainLossOnWarrantDerivativeLiabilities
51000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P2Y3M18D
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4000000
emma Adjustment Of Warrants Change In Fair Value Increase Additional Paid In Capital And Accumulated Loss
AdjustmentOfWarrantsChangeInFairValueIncreaseAdditionalPaidInCapitalAndAccumulatedLoss
446000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-35000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
58000
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2021Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
31000
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
272000
CY2021Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
300000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
263000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1049000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1063000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1092000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
836000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4303000
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
887000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
3416000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2900000
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.129

Files In Submission

Name View Source Status
0001564590-22-037658-index-headers.html Edgar Link pending
0001564590-22-037658-index.html Edgar Link pending
0001564590-22-037658.txt Edgar Link pending
0001564590-22-037658-xbrl.zip Edgar Link pending
emma-10q_20220930.htm Edgar Link pending
emma-20220930.xsd Edgar Link pending
emma-ex101_58.htm Edgar Link pending
emma-ex102_59.htm Edgar Link pending
emma-ex103_60.htm Edgar Link pending
emma-ex104_61.htm Edgar Link pending
emma-ex105_62.htm Edgar Link pending
emma-ex106_63.htm Edgar Link pending
emma-ex107_64.htm Edgar Link pending
emma-ex311_8.htm Edgar Link pending
emma-ex312_6.htm Edgar Link pending
emma-ex321_7.htm Edgar Link pending
emma-ex41_57.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
emma-20220930_def.xml Edgar Link unprocessable
emma-20220930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
emma-10q_20220930_htm.xml Edgar Link completed
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
emma-20220930_cal.xml Edgar Link unprocessable
emma-20220930_pre.xml Edgar Link unprocessable